Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant vs Adjuvant Chemotherapy for Early TNBC or HER2+ Breast Cancer
NCT02934828Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2014
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in breast cancer, sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
paclitaxelcarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02934828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02934828.